BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 17933488)

  • 1. [Systemic treatments of the vasospasm].
    Tavernier B; Decamps F; Vega E; Poidevin P; Verdin M; Riegel B
    Ann Fr Anesth Reanim; 2007 Nov; 26(11):980-4. PubMed ID: 17933488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous magnesium versus nimodipine in the treatment of patients with aneurysmal subarachnoid hemorrhage: a randomized study.
    Schmid-Elsaesser R; Kunz M; Zausinger S; Prueckner S; Briegel J; Steiger HJ
    Neurosurgery; 2006 Jun; 58(6):1054-65; discussion 1054-65. PubMed ID: 16723884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of intraarterial therapy for cerebral vasospasm secondary to aneurysmal subarachnoid hemorrhage.
    Weant KA; Ramsey CN; Cook AM
    Pharmacotherapy; 2010 Apr; 30(4):405-17. PubMed ID: 20334460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Perspectives in the treatment of subarachnoid-hemorrhage-induced cerebral vasospasm].
    Fandino J; Fathi AR; Graupner T; Jacob S; Landolt H
    Neurocirugia (Astur); 2007 Feb; 18(1):16-27. PubMed ID: 17393042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postoperative hypertensive-hypervolaemic-haemodilution (Triple H) therapy in the treatment of vasospasm following aneurysmal subarachnoid haemorrhage.
    Gupta D; Sharma BS; Gupta SK; Bapuraj R; Khosla VK
    Neurol India; 2000 Jun; 48(2):126-31. PubMed ID: 10878775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detecting and treating microvascular ischemia after subarachnoid hemorrhage.
    Sakowitz OW; Unterberg AW
    Curr Opin Crit Care; 2006 Apr; 12(2):103-11. PubMed ID: 16543784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebral vasospasm after aneurysmal subarachnoid hemorrhage: an overview of pharmacologic management.
    Liu-Deryke X; Rhoney DH
    Pharmacotherapy; 2006 Feb; 26(2):182-203. PubMed ID: 16466324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of the selective endothelin A (ET(A)) receptor antagonist Clazosentan on cerebral perfusion and cerebral oxygenation following severe subarachnoid hemorrhage - preliminary results from a randomized clinical series.
    Barth M; Capelle HH; Münch E; Thomé C; Fiedler F; Schmiedek P; Vajkoczy P
    Acta Neurochir (Wien); 2007; 149(9):911-8; discussion 918. PubMed ID: 17700991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Protective measures against cerebral ischemia following subarachnoid hemorrhage: Part 1].
    Romero Kräuchi O; Verger Bennasar AM
    Rev Esp Anestesiol Reanim; 2011 Apr; 58(4):230-5. PubMed ID: 21608279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Triple-H therapy in the management of aneurysmal subarachnoid haemorrhage.
    Sen J; Belli A; Albon H; Morgan L; Petzold A; Kitchen N
    Lancet Neurol; 2003 Oct; 2(10):614-21. PubMed ID: 14505583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statin use was not associated with less vasospasm or improved outcome after subarachnoid hemorrhage.
    Kramer AH; Gurka MJ; Nathan B; Dumont AS; Kassell NF; Bleck TP
    Neurosurgery; 2008 Feb; 62(2):422-7; discussion 427-30. PubMed ID: 18382320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of cerebral vasospasm after subarachnoid hemorrhage--a review.
    Wu CT; Wong CS; Yeh CC; Borel CO
    Acta Anaesthesiol Taiwan; 2004 Dec; 42(4):215-22. PubMed ID: 15679131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Which H is the most important in triple-H therapy for cerebral vasospasm?
    Treggiari MM; Deem S
    Curr Opin Crit Care; 2009 Apr; 15(2):83-6. PubMed ID: 19276798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Endovascular treatment of vasospasm following subarachnoid aneurysmal haemorrhage].
    Abdennour L; Lejean L; Bonneville F; Boch AL; Puybasset L
    Ann Fr Anesth Reanim; 2007 Nov; 26(11):985-9. PubMed ID: 17935940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical review: Prevention and therapy of vasospasm in subarachnoid hemorrhage.
    Keyrouz SG; Diringer MN
    Crit Care; 2007; 11(4):220. PubMed ID: 17705883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feasibility and safety of intrathecal nimodipine on posthaemorrhagic cerebral vasospasm refractory to medical and endovascular therapy.
    Hänggi D; Beseoglu K; Turowski B; Steiger HJ
    Clin Neurol Neurosurg; 2008 Sep; 110(8):784-90. PubMed ID: 18554777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel treatments for vasospasm after subarachnoid hemorrhage.
    Muroi C; Seule M; Mishima K; Keller E
    Curr Opin Crit Care; 2012 Apr; 18(2):119-26. PubMed ID: 22234053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrathecal treatment of cerebral vasospasm.
    Zhang YP; Shields LB; Yao TL; Dashti SR; Shields CB
    J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):1201-11. PubMed ID: 22651990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Recommendations for the management of patients with aneurysmal subarachnoid hemorrhage].
    Raabe A; Beck J; Berkefeld J; Deinsberger W; Meixensberger J; Schmiedek P; Seifert V; Steinmetz H; Unterberg A; Vajkoczy P; Werner C;
    Zentralbl Neurochir; 2005 May; 66(2):79-91. PubMed ID: 15846536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A clinical review of cerebral vasospasm and delayed ischaemia following aneurysm rupture.
    Dorsch N
    Acta Neurochir Suppl; 2011; 110(Pt 1):5-6. PubMed ID: 21116906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.